[
{
"numtree":"1.0.0.0",
"id":"1",
"nametree":"Authors and legal information",
"tocnametree":"Authors and legal information",
"htmlpage":"ENAS5266_1.0.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"2.0.0.0",
"id":"2",
"nametree":"CV eval. before anticancer treatment",
"tocnametree":"CV eval. before anticancer treatment",
"htmlpage":"ENAS5266_2.0.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"3.0.0.0",
"id":"3",
"nametree":"Left ventricular dysfunction (LVD)",
"tocnametree":"Left ventricular dysfunction (LVD)",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"3.1.0.0",
"id":"4",
"nametree":"Overview",
"tocnametree":"Overview",
"htmlpage":"ENAS5266_3.1.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"3.2.0.0",
"id":"5",
"nametree":"Anthracyclines and cardiotoxicity",
"tocnametree":"Anthracyclines and cardiotoxicity",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"3.2.1.0",
"id":"6",
"nametree":"Overview",
"tocnametree":"Overview",
"htmlpage":"ENAS5266_3.2.1.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"3.2.2.0",
"id":"7",
"nametree":"Mgmt. of cardiotoxicity",
"tocnametree":"Mgmt. of cardiotoxicity",
"htmlpage":"ENAS5266_3.2.2.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"3.3.0.0",
"id":"8",
"nametree":"Monoclonal antibodies and targeted agents",
"tocnametree":"Monoclonal antibodies and targeted agents",
"htmlpage":"ENAS5266_3.3.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"3.4.0.0",
"id":"9",
"nametree":"Trastuzumab cardiotox. adjuvant trials",
"tocnametree":"Trastuzumab cardiotox. adjuvant trials",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"3.4.1.0",
"id":"10",
"nametree":"Overview",
"tocnametree":"Overview",
"htmlpage":"ENAS5266_3.4.1.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"3.4.2.0",
"id":"11",
"nametree":"Mgmt. of trastuzumab cardiotoxicity",
"tocnametree":"Mgmt. of trastuzumab cardiotoxicity",
"htmlpage":"ENAS5266_3.4.2.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"3.4.3.0",
"id":"12",
"nametree":"LVEF: Cont./discont. of Trastuzumab",
"tocnametree":"LVEF: Cont./discont. of Trastuzumab",
"htmlpage":"ENAS5266_3.4.3.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"4.0.0.0",
"id":"13",
"nametree":"Cardiac ischaemia",
"tocnametree":"Cardiac ischaemia",
"htmlpage":"ENAS5266_4.0.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"5.0.0.0",
"id":"14",
"nametree":"Hypertension",
"tocnametree":"Hypertension",
"htmlpage":"ENAS5266_5.0.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"6.0.0.0",
"id":"15",
"nametree":"QT prolongation",
"tocnametree":"QT prolongation",
"htmlpage":"ENAS5266_6.0.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"7.0.0.0",
"id":"16",
"nametree":"CV monitoring during & after anticancer Tx",
"tocnametree":"CV monitoring during & after anticancer Tx",
"htmlpage":"ENAS5266_7.0.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"8.0.0.0",
"id":"17",
"nametree":"Tx of LVD induced by anticancer treatment",
"tocnametree":"Tx of LVD induced by anticancer treatment",
"htmlpage":"ENAS5266_8.0.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"9.0.0.0",
"id":"18",
"nametree":"Cardiac toxicity induced by RT",
"tocnametree":"Cardiac toxicity induced by RT",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"9.1.0.0",
"id":"19",
"nametree":"Overview",
"tocnametree":"Overview",
"htmlpage":"ENAS5266_9.1.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"9.2.0.0",
"id":"20",
"nametree":"Recomm. to reduce cardiac toxicity by RT",
"tocnametree":"Recomm. to reduce cardiac toxicity by RT",
"htmlpage":"ENAS5266_9.2.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"9.3.0.0",
"id":"21",
"nametree":"Tx of radiotherapy-related cardiac compli.",
"tocnametree":"Tx of radiotherapy-related cardiac compli.",
"htmlpage":"ENAS5266_9.3.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"9.4.0.0",
"id":"22",
"nametree":"Monitoring of cardiac func. after chest RT",
"tocnametree":"Monitoring of cardiac func. after chest RT",
"htmlpage":"ENAS5266_9.4.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"10.0.0.0",
"id":"23",
"nametree":"Summary of recommendations",
"tocnametree":"Summary of recommendations",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"10.1.0.0",
"id":"24",
"nametree":"CV eval. before anticancer treatment",
"tocnametree":"CV eval. before anticancer treatment",
"htmlpage":"ENAS5266_10.1.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"10.2.0.0",
"id":"25",
"nametree":"Left ventricular dysfunction (LVD)",
"tocnametree":"Left ventricular dysfunction (LVD)",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"10.2.1.0",
"id":"26",
"nametree":"Overview",
"tocnametree":"Overview",
"htmlpage":"ENAS5266_10.2.1.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"10.2.2.0",
"id":"27",
"nametree":"Anthracyclines and cardiotoxicity",
"tocnametree":"Anthracyclines and cardiotoxicity",
"htmlpage":"ENAS5266_10.2.2.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"10.2.3.0",
"id":"28",
"nametree":"Monoclonal antibodies and targeted agents",
"tocnametree":"Monoclonal antibodies and targeted agents",
"htmlpage":"ENAS5266_10.2.3.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"10.2.4.0",
"id":"29",
"nametree":"Mgmt. of trastuzumab cardiotoxicity",
"tocnametree":"Mgmt. of trastuzumab cardiotoxicity",
"htmlpage":"ENAS5266_10.2.4.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"10.3.0.0",
"id":"30",
"nametree":"Cardiac ischaemia",
"tocnametree":"Cardiac ischaemia",
"htmlpage":"ENAS5266_10.3.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"10.4.0.0",
"id":"31",
"nametree":"Hypertension",
"tocnametree":"Hypertension",
"htmlpage":"ENAS5266_10.4.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"10.5.0.0",
"id":"32",
"nametree":"QT prolongation",
"tocnametree":"QT prolongation",
"htmlpage":"ENAS5266_10.5.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"10.6.0.0",
"id":"33",
"nametree":"CV monitoring during & after anticancer Tx",
"tocnametree":"CV monitoring during & after anticancer Tx",
"htmlpage":"ENAS5266_10.6.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"10.7.0.0",
"id":"34",
"nametree":"Tx of LVD induced by anticancer treatment",
"tocnametree":"Tx of LVD induced by anticancer treatment",
"htmlpage":"ENAS5266_10.7.0.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"10.8.0.0",
"id":"35",
"nametree":"Cardiac toxicity induced by RT",
"tocnametree":"Cardiac toxicity induced by RT",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"10.8.1.0",
"id":"36",
"nametree":"Overview",
"tocnametree":"Overview",
"htmlpage":"ENAS5266_10.8.1.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"10.8.2.0",
"id":"37",
"nametree":"Recomm. to reduce cardiac toxicity in RT",
"tocnametree":"Recomm. to reduce cardiac toxicity in RT",
"htmlpage":"ENAS5266_10.8.2.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"10.8.3.0",
"id":"38",
"nametree":"Monitoring of cardiac func. after chest RT",
"tocnametree":"Monitoring of cardiac func. after chest RT",
"htmlpage":"ENAS5266_10.8.3.0",
"haspdf":false,
"emailContent":true
},
{
"numtree":"11.0.0.0",
"id":"39",
"nametree":"Glossary",
"tocnametree":"Glossary",
"htmlpage":"ENAS5266_11.0.0.0",
"haspdf":false,
"emailContent":true
}
]